Collectively, these findings indicated that KPC1 is, at least, one of the downstream substrates (i.e., editing targets) by ADAR1-p110, and its editing mutation p.M8V is required for ADAR1-p110 to play its oncogenic role in the development of iCCA. This evidence concerns the gene RNF123 and infantile convulsions and choreoathetosis.